Penbrook Management’s Profound Medical PROF Stock Holding History

Penbrook Management’s Portfolio PROF Stock Details PROF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$66K	Sell	11,375 -700	-6%	-$4.76K	0.04%	101
2026 Q2	$80.3K	Sell	12,075 -225	-2%	-$1.51K	0.05%	101
2026 Q1	$79.7K	Buy	+12,300	New	+$85K	0.06%	92

Other funds holding PROF

RMC

Ring Mountain Capital Tiburon, California $245M AUM 48.62% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return

Penbrook Management's PROF Position: Q3 2026 in Review

Penbrook Management reduced its Profound Medical (PROF) stake by 5.8% in Q3 2026, selling an estimated $4.76K and leaving 11,375 shares worth $66K. The position accounts for 0.04% of the portfolio, ranked #101.

Penbrook Management first reported a position in PROF in Q1 2026 and has held it in 3 quarters since. The position peaked at $80.3K in Q2 2026. 4 funds tracked by Wall St. Rank hold PROF as of Q3 2026.

Penbrook Management held 11,375 shares of Profound Medical worth $66K as of Q3 2026.
Penbrook Management sold 700 Profound Medical shares in Q3 2026, an estimated $4.76K.
Profound Medical made up 0.04% of Penbrook Management's portfolio in Q3 2026, its #101 holding.
Penbrook Management first reported a position in Profound Medical in Q1 2026 and has held it in 3 quarters since.
Penbrook Management's Profound Medical position peaked at $80.3K in Q2 2026.
4 funds tracked by Wall St. Rank held Profound Medical as of Q3 2026.

Based on Penbrook Management's 13F filing for Q3 2026, filed 16 Oct 2026.